1. Home
  2. AVTX
  3. AVTX News

Latest Avalo Therapeutics Inc. (AVTX) News on November 27, 2025

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
AVTX

GlobeNewswire

9 days ago

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Leukocyte Adhesion Deficiency Market Analysis and Forecast, 2025-2035, Featuring Rocket Pharmaceuticals, Avalo Therapeutics, Orpha Labs, and AUG Therapeutics
AVTX

GlobeNewswire

15 days ago

Leukocyte Adhesion Deficiency Market Analysis and Forecast, 2025-2035, Featuring Rocket Pharmaceuticals, Avalo Therapeutics, Orpha Labs, and AUG Therapeutics

Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates
AVTX

GlobeNewswire

21 days ago

Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates

Avalo Therapeutics to Participate in Upcoming Investor Conferences
AVTX

GlobeNewswire

24 days ago

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Piper Sandler Maintains Bullish $48 Price Target on Avalo Therapeutics (AVTX)
AVTX

Insider Monkey

a month ago

Piper Sandler Maintains Bullish $48 Price Target on Avalo Therapeutics (AVTX)

AVTX

MT Newswires

3 months ago

TD Cowen Initiates Avalo Therapeutics at Buy

Avalo Therapeutics to Participate in Upcoming Investor Conferences
AVTX

GlobeNewswire

5 months ago

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
AVTX

GlobeNewswire

5 months ago

Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors

Avalo Therapeutics to Participate in Upcoming Investor Conferences
AVTX

GlobeNewswire

6 months ago

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
AVTX

GlobeNewswire

7 months ago

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
AVTX

GlobeNewswire

8 months ago

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

Avalo Reports 2024 Financial Results and Recent Business Updates
AVTX

GlobeNewswire

8 months ago

Avalo Reports 2024 Financial Results and Recent Business Updates

Avalo Therapeutics to Participate in Upcoming Investor Conferences
AVTX

GlobeNewswire

9 months ago

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
AVTX

GlobeNewswire

10 months ago

Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
AVTX

GlobeNewswire

a year ago

Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer

Avalo Therapeutics initiated with a Buy at BTIG
AVTX

TipRanks

a year ago

Avalo Therapeutics initiated with a Buy at BTIG

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
AVTX

GlobeNewswire

a year ago

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants

Avalo Therapeutics to Present at Upcoming Investor Conferences
AVTX

GlobeNewswire

a year ago

Avalo Therapeutics to Present at Upcoming Investor Conferences

Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates
AVTX

GlobeNewswire

a year ago

Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates

Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
AVTX

GlobeNewswire

a year ago

Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

Avalo Announces Participation in September Investor Conferences
AVTX

GlobeNewswire

a year ago

Avalo Announces Participation in September Investor Conferences

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
AVTX

GlobeNewswire

a year ago

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
AVTX

GlobeNewswire

a year ago

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer

Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa
AVTX

GlobeNewswire

a year ago

Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa

Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
AVTX

GlobeNewswire

a year ago

Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer

Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
AVTX

GlobeNewswire

a year ago

Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit

Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
AVTX

GlobeNewswire

2 years ago

Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
AVTX

GlobeNewswire

2 years ago

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

Avalo Reports 2023 Financial Results and Provides Business Updates
AVTX

GlobeNewswire

2 years ago

Avalo Reports 2023 Financial Results and Provides Business Updates

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
AVTX

GlobeNewswire

2 years ago

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million

NeuroSense’s (NASDAQ:NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024
AVTX

ACCESSWIRE

2 years ago

NeuroSense’s (NASDAQ:NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering
AVTX

PR Newswire

2 years ago

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
AVTX

GlobeNewswire

2 years ago

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023
AVTX

GlobeNewswire

2 years ago

Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
AVTX

GlobeNewswire

2 years ago

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

Eco Wave Power Submits an Official Request to the SFSA to Receive an Authorization for the Repurchase of American Depositary Shares Representing Up to 10% of the Company's Shares
AVTX

PR Newswire

2 years ago

Eco Wave Power Submits an Official Request to the SFSA to Receive an Authorization for the Repurchase of American Depositary Shares Representing Up to 10% of the Company's Shares

Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
AVTX

GlobeNewswire

2 years ago

Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split

17 Education & Technology Group Inc. Announces Third Quarter 2023 Unaudited Financial Results
AVTX

GlobeNewswire

2 years ago

17 Education & Technology Group Inc. Announces Third Quarter 2023 Unaudited Financial Results

Bitcoin Depot Founder and CEO Brandon Mintz Honored in Forbes 30 Under 30 Finance List
AVTX

GlobeNewswire

2 years ago

Bitcoin Depot Founder and CEO Brandon Mintz Honored in Forbes 30 Under 30 Finance List

Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
AVTX

GlobeNewswire

2 years ago

Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology

Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics
AVTX

Zacks

2 years ago

Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
AVTX

Business Wire

2 years ago

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings
AVTX

PR Newswire

2 years ago

PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings

NanoString Comments on Delaware District Court Verdict
AVTX

Business Wire

2 years ago

NanoString Comments on Delaware District Court Verdict

Here's What's Concerning About United-Guardian's (NASDAQ:UG) Returns On Capital
AVTX

Simply Wall St.

2 years ago

Here's What's Concerning About United-Guardian's (NASDAQ:UG) Returns On Capital

Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results
AVTX

GlobeNewswire

2 years ago

Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results

Longeveron Inc. (NASDAQ:LGVN) Q3 2023 Earnings Call Transcript
AVTX

Insider Monkey

2 years ago

Longeveron Inc. (NASDAQ:LGVN) Q3 2023 Earnings Call Transcript

AVTX

Business Wire

2 years ago

Mogo Reports Results for Q3 2023

Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
AVTX

GlobeNewswire

2 years ago

Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates

ShotSpotter, Inc. (NASDAQ:SSTI) Q3 2023 Earnings Call Transcript
AVTX

Insider Monkey

2 years ago

ShotSpotter, Inc. (NASDAQ:SSTI) Q3 2023 Earnings Call Transcript

NetSol Technologies, Inc. (NASDAQ:NTWK) Q1 2024 Earnings Call Transcript
AVTX

Insider Monkey

2 years ago

NetSol Technologies, Inc. (NASDAQ:NTWK) Q1 2024 Earnings Call Transcript

Paltalk, Inc. (NASDAQ:PALT) Q3 2023 Earnings Call Transcript
AVTX

Insider Monkey

2 years ago

Paltalk, Inc. (NASDAQ:PALT) Q3 2023 Earnings Call Transcript

Kingstone Announces Estimated Third Quarter 2023 Catastrophe
AVTX

ACCESSWIRE

2 years ago

Kingstone Announces Estimated Third Quarter 2023 Catastrophe

Seven Hills Realty Trust Announces Third Quarter 2023 Results
AVTX

Business Wire

2 years ago

Seven Hills Realty Trust Announces Third Quarter 2023 Results

Share on Social Networks: